Press Releases Year None202020192018201720162015 May 07, 2020 Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update May 07, 2020 Ovid Therapeutics Announces Positive Topline Results from the Phase 2 ROCKET Trial of OV101 for the Treatment of Fragile X Syndrome Mar 30, 2020 Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome Mar 11, 2020 Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020 Mar 05, 2020 Ovid Therapeutics Announces Multiple Presentations at the American Academy of Neurology 2020 Annual Meeting Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page next › Last page last »
